History
  • No items yet
midpage
930 F.3d 1031
9th Cir.
2019
Read the full case

Background

  • Ixchel Pharma (developer of a dimethyl fumarate drug) entered a January 2016 Collaboration Agreement with Forward Pharma; Forward could terminate on 60 days’ notice.
  • Forward negotiated a separate settlement with Biogen in Jan. 2017 in which Biogen paid Forward $1.25 billion and Forward agreed (via §2.13) to terminate and not enter contracts with Ixchel relating to dimethyl fumarate products.
  • Ixchel sued Biogen in federal court for tortious interference with contract, interference with prospective economic advantage, and UCL violations; district court dismissed for failure to plead an independently wrongful act and that §16600 did not apply.
  • Ixchel amended to allege §16600 barred Forward’s agreement with Biogen and that the §16600 violation was an independently wrongful act; the district court again dismissed.
  • The Ninth Circuit panel concluded the determinative issues are unsettled questions of California law and certified two questions to the California Supreme Court rather than resolving them itself.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Does Cal. Bus. & Prof. Code §16600 void contracts restraining a business from dealing with another business (i.e., apply beyond employer–employee covenants)? §16600’s plain text applies to “anyone” and should be read broadly to bar restraints between businesses; thus §2.13 likely void and constitutes an independently wrongful act. §16600 is limited to employment covenants; a broad reading would invalidate ordinary commercial arrangements and contradict policy and federal rule-of-reason antitrust principles. Certified to the California Supreme Court for authoritative resolution.
Whether a plaintiff must plead an independently wrongful act to state intentional interference with a contract terminable at will outside the employment context (Reeves scope). Reeves’ independently-wrongful-act requirement should be limited to at-will employment; it should not extend to non-employment at-will contracts. Reeves’ requirement should apply whenever a contract is terminable at will by a party, regardless of employment context. Certified to the California Supreme Court for authoritative resolution.

Key Cases Cited

  • Edwards v. Arthur Andersen LLP, 44 Cal. 4th 937 (establishes broad interpretation of §16600 and rejection of a narrow-restraint exception)
  • Reeves v. Hanlon, 33 Cal. 4th 1140 (holds plaintiff must plead an independently wrongful act to state interference claim involving at-will employment)
  • Pac. Gas & Elec. Co. v. Bear Stearns & Co., 50 Cal. 3d 1118 (sets elements for intentional interference with contractual relations)
  • Golden v. California Emergency Physicians Med. Grp., 782 F.3d 1083 (Ninth Circuit reading of Edwards regarding §16600’s scope in employment context)
  • Korea Supply Co. v. Lockheed Martin Corp., 29 Cal. 4th 1134 (defines what qualifies as an independently wrongful act for UCL/interference contexts)
  • Great W. Distillery Prods., Inc. v. John A. Wathen Distillery Co., 10 Cal. 2d 442 (historical application of predecessor to §16600 in non-employment settings)
Read the full case

Case Details

Case Name: Ixchel Pharma, LLC v. Biogen, Inc.
Court Name: Court of Appeals for the Ninth Circuit
Date Published: Jul 16, 2019
Citations: 930 F.3d 1031; 18-15258
Docket Number: 18-15258
Court Abbreviation: 9th Cir.
Log In
    Ixchel Pharma, LLC v. Biogen, Inc., 930 F.3d 1031